In this article, our CEO Tuomas Tenkanen is presenting our upcoming Novodiag® molecular diagnostics solution. It also presents how Mobidiag is bringing alternative solutions to the routine diagnostics of infectious diseases by making rapid and cost-effective DNA-based technology accessible to all sizes of clinical laboratories.
